Correlation Between Syndax Pharmaceuticals and Context Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Context Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Context Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Context Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Context Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Context Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Context Therapeutics.

Diversification Opportunities for Syndax Pharmaceuticals and Context Therapeutics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Syndax and Context is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Context Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Context Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Context Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Context Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Context Therapeutics go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Context Therapeutics

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 1.41 times less return on investment than Context Therapeutics. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 1.33 times less risky than Context Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Context Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  85.00  in Context Therapeutics on September 1, 2025 and sell it today you would earn a total of  27.00  from holding Context Therapeutics or generate 31.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Syndax Pharmaceuticals  vs.  Context Therapeutics

 Performance 
       Timeline  
Syndax Pharmaceuticals 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Syndax Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile fundamental indicators, Syndax Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Context Therapeutics 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Context Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Context Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Syndax Pharmaceuticals and Context Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Syndax Pharmaceuticals and Context Therapeutics

The main advantage of trading using opposite Syndax Pharmaceuticals and Context Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Context Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Context Therapeutics will offset losses from the drop in Context Therapeutics' long position.
The idea behind Syndax Pharmaceuticals and Context Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites